The European Chemicals Agency (ECHA) has announced that the Public Activities Coordination Tool (PACT) has been updated with the publication of several new intentions for hazard assessment, three new intentions for risk management option analysis (RMOA) development and three RMOA conclusion documents.
Sweden is carrying out the assessment for endocrine disrupting properties of dicyclohexyl phthalate (EC 201-545-9). Seven new intentions for carrying out PBT assessment (of non-CoRAP) substances were also added to the list.
Three new RMOA intentions were notified by the Netherlands, for p-phenylenediamine (EC 203-404-7), [4-[α-[4-(dimethylamino)phenyl] benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium acetate (EC 255-288-2) and Indium tin oxide (EC 610-589-1). In addition, three RMOA conclusion documents have been published, two by Sweden and one by Denmark. For perfluorononan-1-oic acid (2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononanoic acid and its sodium and ammonium salts (EC 206-801-3) and hexamethylene diacrylate (hexane-1,6-diol diacrylate, EC 255-288-2)) there is a need to initiate further regulatory risk management action at EU level in the form of the identification as a substance of very high concern under REACH. For 2-methyl-2H-isothiazol-3-one (EC 220-239-6)) it is suggested to consider action under other legislation than REACH. Further information is available at: PACT – RMOA and hazard assessment activities
ECHA enew,6 May 2015 ;http://echa.europa.eu ;